Planning for Success in Your Lymphoma Studies
Lymphoma is one of the most common – and diverse – types of blood cancer. According to the Lymphoma Research Society, more than 90 types of non-Hodgkin lymphoma (NHL) exist, and more than 80,000 new cases of NHL occur in the United States each year. There are also at least six distinct types of Hodgkin lymphoma (HL), and approximately 9,000 cases of HL occur in the United States each year.
HL can be cured in most cases. NHL has proven more resistant to cures. Radiation and chemotherapy treatments have been part of the traditional therapeutic arsenal. More recently, researchers have been looking at exciting new approaches to NHL, including stem cell transplants and immunotherapies that stimulate the body’s own immune system to fight the disease.
Are you working on a novel approach to lymphoma? You’ll want a partner to help you proceed through the maze of clinical trials.
No CRO is better positioned to do this than Worldwide Clinical Trials. We have more than 30 years of experience supporting research in oncology, immune-mediated inflammatory disorders (IMID), and novel therapy development. We are internationally acclaimed experts in clinical trial management, offering full-service support for Phase I-Phase IV clinical trials as well as real-world evidence clinical research services. Moreover, we have a proven track record for staffing projects with stable teams of professionals who are already experienced in all phases of project planning, analysis, data collection and management.
Are you ready to move forward? Talk to the experts at Worldwide before you take the next step.